Molecular Pharmacology 2015-09-01

Ligand Residence Time at G-protein-Coupled Receptors-Why We Should Take Our Time To Study It.

C Hoffmann, M Castro, A Rinken, R Leurs, S J Hill, H F Vischer

Index: Mol. Pharmacol. 88 , 552-60, (2015)

Full Text: HTML

Abstract

Over the past decade the kinetics of ligand binding to a receptor have received increasing interest. The concept of drug-target residence time is becoming an invaluable parameter for drug optimization. It holds great promise for drug development, and its optimization is thought to reduce off-target effects. The success of long-acting drugs like tiotropium support this hypothesis. Nonetheless, we know surprisingly little about the dynamics and the molecular detail of the drug binding process. Because protein dynamics and adaptation during the binding event will change the conformation of the protein, ligand binding will not be the static process that is often described. This can cause problems because simple mathematical models often fail to adequately describe the dynamics of the binding process. In this minireview we will discuss the current situation with an emphasis on G-protein-coupled receptors. These are important membrane protein drug targets that undergo conformational changes upon agonist binding to communicate signaling information across the plasma membrane of cells. Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.


Related Compounds

  • JNJ-7777120

Related Articles:

Involvement of the H1 Histamine Receptor, p38 MAP Kinase, Myosin Light Chains Kinase, and Rho/ROCK in Histamine-Induced Endothelial Barrier Dysfunction.

2015-05-01

[Microcirculation 22 , 237-48, (2015)]

Histamine H4 receptor as a new therapeutic target for choroidal neovascularization in age-related macular degeneration.

2014-08-01

[Br. J. Pharmacol. 171(15) , 3754-63, (2014)]

Analysis of the histamine H2-receptor in human monocytes.

2014-11-15

[Biochem. Pharmacol. 92(2) , 369-79, (2014)]

The first potent and selective non-imidazole human histamine H4 receptor antagonists.

2003-09-11

[J. Med. Chem. 46 , 3957-3960, (2003)]

Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines.

2010-01-01

[Respir. Res. 11 , 86, (2010)]

More Articles...